APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Acamprosate

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Acamprosate Market Outlook and Growth Opportunities 2026

Report ID 173959460420 December 2025192 pages

Choose your research edition.

Industry ResearchAcamprosate Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Acamprosate Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Acamprosate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Acamprosate Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Acamprosate Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Acamprosate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Acamprosate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Acamprosate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Acamprosate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Acamprosate market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Acamprosate market include Teva, Merck Group, Mylan, Zydus Pharmaceuticals and Glenmark Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Acamprosate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Acamprosate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Acamprosate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Acamprosate market size, projected growth trends, production technologies, key applications, and end-use industries.

Acamprosate Segment by Company

Teva

Merck Group

Mylan

Zydus Pharmaceuticals

Glenmark Pharmaceuticals

Acamprosate Segment by Type

333 mg Delayed Release Tablet

Others

Acamprosate Segment by Application

Hospital

Clinic

Others

Acamprosate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Acamprosate status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Acamprosate market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Acamprosate significant trends, drivers, influence factors in global and regions.

6. To analyze Acamprosate competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acamprosate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acamprosate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acamprosate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Acamprosate market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Acamprosate industry.

Chapter 3: Detailed analysis of Acamprosate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Acamprosate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Acamprosate in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Acamprosate Industry Trends Table 2. Acamprosate Industry Drivers Table 3. Acamprosate Industry Opportunities and Challenges Table 4. Acamprosate Industry Restraints Table 5. Global Acamprosate Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Acamprosate Revenue Share by Company (2021-2026) Table 7. Global Acamprosate Sales Volume by Company (K Pcs) & (2021-2026) Table 8. Global Acamprosate Sales Volume Share by Company (2021-2026) Table 9. Global Acamprosate Average Price (US$/Pcs) of Company (2021-2026) Table 10. Global Acamprosate Company Ranking, (2024-2026) & (USD Million) Table 11. Global Acamprosate Key Company Manufacturing Base & Headquarters Table 12. Global Acamprosate Company, Product Type & Application Table 13. Global Acamprosate Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Acamprosate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 333 mg Delayed Release Tablet Table 18. Significant Companies of Others Table 19. Global Acamprosate Sales Volume by Type 2021 VS 2025 VS 2032 (K Pcs) Table 20. Global Acamprosate Sales Volume by Type (2021-2026) & (K Pcs) Table 21. Global Acamprosate Sales Volume by Type (2027-2032) & (K Pcs) Table 22. Global Acamprosate Sales Volume Share by Type (2021-2026) Table 23. Global Acamprosate Sales Volume Share by Type (2027-2032) Table 24. Global Acamprosate Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Acamprosate Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Acamprosate Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Acamprosate Sales Value Share by Type (2021-2026) Table 28. Global Acamprosate Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Others Table 32. Global Acamprosate Sales Volume by Application 2021 VS 2025 VS 2032 (K Pcs) Table 33. Global Acamprosate Sales Volume by Application (2021-2026) & (K Pcs) Table 34. Global Acamprosate Sales Volume by Application (2027-2032) & (K Pcs) Table 35. Global Acamprosate Sales Volume Share by Application (2021-2026) Table 36. Global Acamprosate Sales Volume Share by Application (2027-2032) Table 37. Global Acamprosate Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Acamprosate Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Acamprosate Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Acamprosate Sales Value Share by Application (2021-2026) Table 41. Global Acamprosate Sales Value Share by Application (2027-2032) Table 42. Global Acamprosate Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Table 43. Global Acamprosate Sales by Region (2021-2026) & (K Pcs) Table 44. Global Acamprosate Sales Market Share by Region (2021-2026) Table 45. Global Acamprosate Sales by Region (2027-2032) & (K Pcs) Table 46. Global Acamprosate Sales Market Share by Region (2027-2032) Table 47. Global Acamprosate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Acamprosate Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Acamprosate Sales Value Share by Region (2021-2026) Table 50. Global Acamprosate Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Acamprosate Sales Value Share by Region (2027-2032) Table 52. Global Acamprosate Market Average Price (US$/Pcs) by Region (2021-2026) Table 53. Global Acamprosate Market Average Price (US$/Pcs) by Region (2027-2032) Table 54. Global Acamprosate Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Table 55. Global Acamprosate Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Acamprosate Sales by Country (2021-2026) & (K Pcs) Table 57. Global Acamprosate Sales Market Share by Country (2021-2026) Table 58. Global Acamprosate Sales by Country (2027-2032) & (K Pcs) Table 59. Global Acamprosate Sales Market Share by Country (2027-2032) Table 60. Global Acamprosate Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Acamprosate Sales Value Market Share by Country (2021-2026) Table 62. Global Acamprosate Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Acamprosate Sales Value Market Share by Country (2027-2032) Table 64. Teva Company Information Table 65. Teva Business Overview Table 66. Teva Acamprosate Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 67. Teva Acamprosate Product Portfolio Table 68. Teva Recent Development Table 69. Merck Group Company Information Table 70. Merck Group Business Overview Table 71. Merck Group Acamprosate Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 72. Merck Group Acamprosate Product Portfolio Table 73. Merck Group Recent Development Table 74. Mylan Company Information Table 75. Mylan Business Overview Table 76. Mylan Acamprosate Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 77. Mylan Acamprosate Product Portfolio Table 78. Mylan Recent Development Table 79. Zydus Pharmaceuticals Company Information Table 80. Zydus Pharmaceuticals Business Overview Table 81. Zydus Pharmaceuticals Acamprosate Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 82. Zydus Pharmaceuticals Acamprosate Product Portfolio Table 83. Zydus Pharmaceuticals Recent Development Table 84. Glenmark Pharmaceuticals Company Information Table 85. Glenmark Pharmaceuticals Business Overview Table 86. Glenmark Pharmaceuticals Acamprosate Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 87. Glenmark Pharmaceuticals Acamprosate Product Portfolio Table 88. Glenmark Pharmaceuticals Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. Acamprosate Distributors List Table 92. Acamprosate Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Acamprosate Product Image Figure 2. Global Acamprosate Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Acamprosate Sales Value (2021-2032) & (US$ Million) Figure 4. Global Acamprosate Sales (2021-2032) & (K Pcs) Figure 5. Global Acamprosate Sales Average Price (US$/Pcs) & (2021-2032) Figure 6. Global Acamprosate Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 333 mg Delayed Release Tablet Image Figure 10. Others Image Figure 11. Global Acamprosate Sales Volume by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 12. Global Acamprosate Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Acamprosate Sales Volume Share by Type (2021-2032) Figure 14. Global Acamprosate Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Acamprosate Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Acamprosate Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Others Image Figure 20. Global Acamprosate Sales Volume by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 21. Global Acamprosate Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Acamprosate Sales Volume Share by Application (2021-2032) Figure 23. Global Acamprosate Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Acamprosate Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Acamprosate Sales Value Share by Application (2021-2032) Figure 26. Global Acamprosate Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Figure 27. Global Acamprosate Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Acamprosate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Acamprosate Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Acamprosate Sales Value (2021-2032) & (US$ Million) Figure 31. North America Acamprosate Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Acamprosate Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Acamprosate Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Acamprosate Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Acamprosate Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Acamprosate Sales Value (2021-2032) & (US$ Million) Figure 37. South America Acamprosate Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Acamprosate Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Acamprosate Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Acamprosate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Acamprosate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Acamprosate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Acamprosate Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Acamprosate Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 333 mg Delayed Release Tablet
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Teva
  • Merck Group
  • Mylan
  • Zydus Pharmaceuticals
  • Glenmark Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Acamprosate Sales Value (2021-2032)
  4. 1.2.2 Global Acamprosate Sales Volume (2021-2032)
  5. 1.2.3 Global Acamprosate Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Acamprosate Market Dynamics
  1. 2.1 Acamprosate Industry Trends
  2. 2.2 Acamprosate Industry Drivers
  3. 2.3 Acamprosate Industry Opportunities and Challenges
  4. 2.4 Acamprosate Industry Restraints
3 Acamprosate Market by Company
  1. 3.1 Global Acamprosate Company Revenue Ranking in 2025
  2. 3.2 Global Acamprosate Revenue by Company (2021-2026)
  3. 3.3 Global Acamprosate Sales Volume by Company (2021-2026)
  4. 3.4 Global Acamprosate Average Price by Company (2021-2026)
  5. 3.5 Global Acamprosate Company Ranking (2024-2026)
  6. 3.6 Global Acamprosate Company Manufacturing Base and Headquarters
  7. 3.7 Global Acamprosate Company Product Type and Application
  8. 3.8 Global Acamprosate Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Acamprosate Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Acamprosate Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Acamprosate Market by Type
  1. 4.1 Acamprosate Type Introduction
  2. 4.1.1 333 mg Delayed Release Tablet
  3. 4.1.2 Others
  4. 4.2 Global Acamprosate Sales Volume by Type
  5. 4.2.1 Global Acamprosate Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Acamprosate Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Acamprosate Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Acamprosate Sales Value by Type
  9. 4.3.1 Global Acamprosate Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Acamprosate Sales Value by Type (2021-2032)
  11. 4.3.3 Global Acamprosate Sales Value Share by Type (2021-2032)
5 Acamprosate Market by Application
  1. 5.1 Acamprosate Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Acamprosate Sales Volume by Application
  6. 5.2.1 Global Acamprosate Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Acamprosate Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Acamprosate Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Acamprosate Sales Value by Application
  10. 5.3.1 Global Acamprosate Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Acamprosate Sales Value by Application (2021-2032)
  12. 5.3.3 Global Acamprosate Sales Value Share by Application (2021-2032)
6 Acamprosate Regional Sales and Value Analysis
  1. 6.1 Global Acamprosate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Acamprosate Sales by Region (2021-2032)
  3. 6.2.1 Global Acamprosate Sales by Region: 2021-2026
  4. 6.2.2 Global Acamprosate Sales by Region (2027-2032)
  5. 6.3 Global Acamprosate Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Acamprosate Sales Value by Region (2021-2032)
  7. 6.4.1 Global Acamprosate Sales Value by Region: 2021-2026
  8. 6.4.2 Global Acamprosate Sales Value by Region (2027-2032)
  9. 6.5 Global Acamprosate Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Acamprosate Sales Value (2021-2032)
  12. 6.6.2 North America Acamprosate Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Acamprosate Sales Value (2021-2032)
  15. 6.7.2 Europe Acamprosate Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Acamprosate Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Acamprosate Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Acamprosate Sales Value (2021-2032)
  21. 6.9.2 South America Acamprosate Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Acamprosate Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Acamprosate Sales Value Share by Country, 2025 VS 2032
7 Acamprosate Country-level Sales and Value Analysis
  1. 7.1 Global Acamprosate Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Acamprosate Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Acamprosate Sales by Country (2021-2032)
  4. 7.3.1 Global Acamprosate Sales by Country (2021-2026)
  5. 7.3.2 Global Acamprosate Sales by Country (2027-2032)
  6. 7.4 Global Acamprosate Sales Value by Country (2021-2032)
  7. 7.4.1 Global Acamprosate Sales Value by Country (2021-2026)
  8. 7.4.2 Global Acamprosate Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Acamprosate Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Acamprosate Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Acamprosate Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Acamprosate Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Acamprosate Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Acamprosate Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Acamprosate Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Acamprosate Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Acamprosate Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Acamprosate Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Acamprosate Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Acamprosate Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Acamprosate Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Acamprosate Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Acamprosate Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Acamprosate Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Acamprosate Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Acamprosate Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Acamprosate Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Acamprosate Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Acamprosate Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Acamprosate Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Acamprosate Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Acamprosate Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Acamprosate Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Acamprosate Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Acamprosate Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Acamprosate Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Acamprosate Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Acamprosate Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Acamprosate Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Acamprosate Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Acamprosate Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Acamprosate Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Acamprosate Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Acamprosate Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Acamprosate Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Acamprosate Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Acamprosate Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Acamprosate Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Acamprosate Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Acamprosate Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Acamprosate Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Acamprosate Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Acamprosate Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Acamprosate Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Acamprosate Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Acamprosate Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Acamprosate Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Acamprosate Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Acamprosate Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Acamprosate Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Acamprosate Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Acamprosate Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Acamprosate Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Acamprosate Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Acamprosate Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Acamprosate Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Acamprosate Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Acamprosate Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Acamprosate Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Acamprosate Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Acamprosate Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Acamprosate Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Acamprosate Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Acamprosate Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Acamprosate Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Acamprosate Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Acamprosate Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Acamprosate Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Acamprosate Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Acamprosate Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Acamprosate Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Acamprosate Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Acamprosate Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Acamprosate Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Acamprosate Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Acamprosate Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Acamprosate Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Acamprosate Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Acamprosate Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Acamprosate Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Acamprosate Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Acamprosate Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Acamprosate Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Acamprosate Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Merck Group
  8. 8.2.1 Merck Group Company Information
  9. 8.2.2 Merck Group Business Overview
  10. 8.2.3 Merck Group Acamprosate Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck Group Acamprosate Product Portfolio
  12. 8.2.5 Merck Group Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Acamprosate Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Acamprosate Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Zydus Pharmaceuticals
  20. 8.4.1 Zydus Pharmaceuticals Company Information
  21. 8.4.2 Zydus Pharmaceuticals Business Overview
  22. 8.4.3 Zydus Pharmaceuticals Acamprosate Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Zydus Pharmaceuticals Acamprosate Product Portfolio
  24. 8.4.5 Zydus Pharmaceuticals Recent Developments
  25. 8.5 Glenmark Pharmaceuticals
  26. 8.5.1 Glenmark Pharmaceuticals Company Information
  27. 8.5.2 Glenmark Pharmaceuticals Business Overview
  28. 8.5.3 Glenmark Pharmaceuticals Acamprosate Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Glenmark Pharmaceuticals Acamprosate Product Portfolio
  30. 8.5.5 Glenmark Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Acamprosate Value Chain Analysis
  2. 9.1.1 Acamprosate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Acamprosate Sales Mode & Process
  6. 9.2 Acamprosate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Acamprosate Distributors
  9. 9.2.3 Acamprosate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst